N. Schleinitz

11.8k total citations · 1 hit paper
169 papers, 3.3k citations indexed

About

N. Schleinitz is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, N. Schleinitz has authored 169 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Rheumatology, 54 papers in Epidemiology and 42 papers in Immunology. Recurrent topics in N. Schleinitz's work include IgG4-Related and Inflammatory Diseases (31 papers), Neuroendocrine Tumor Research Advances (22 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). N. Schleinitz is often cited by papers focused on IgG4-Related and Inflammatory Diseases (31 papers), Neuroendocrine Tumor Research Advances (22 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). N. Schleinitz collaborates with scholars based in France, United States and Italy. N. Schleinitz's co-authors include Jean‐Robert Harlé, Mikaël Ebbo, Frédéric Vely, Éric Vivier, A. Grados, E. Bernit, Lionel Galicier, Jean‐François Viallard, Marion Malphettes and Claire Fieschi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

N. Schleinitz

148 papers receiving 3.3k citations

Hit Papers

The 2019 American College of Rheumatology/European League... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Schleinitz France 27 1.2k 1.1k 1.1k 702 544 169 3.3k
Camille Françès France 36 562 0.5× 1.1k 1.0× 806 0.8× 492 0.7× 255 0.5× 120 4.0k
Erkan Alpsoy Türkiye 34 585 0.5× 1.4k 1.3× 637 0.6× 224 0.3× 406 0.7× 132 3.9k
Jean‐François Viallard France 31 1.8k 1.5× 451 0.4× 510 0.5× 437 0.6× 1.3k 2.4× 171 3.8k
Jean‐David Bouaziz France 30 3.6k 3.0× 970 0.9× 1.1k 1.0× 399 0.6× 318 0.6× 171 6.1k
Margot S. Peters United States 33 638 0.5× 1.3k 1.1× 652 0.6× 506 0.7× 175 0.3× 117 3.4k
Ralf Waßmuth Germany 33 652 0.5× 570 0.5× 336 0.3× 660 0.9× 276 0.5× 127 3.7k
Wolfgang Schlumberger Germany 27 647 0.5× 727 0.6× 768 0.7× 400 0.6× 119 0.2× 63 2.8k
Franco Rongioletti Italy 34 482 0.4× 587 0.5× 1.3k 1.2× 435 0.6× 185 0.3× 306 4.5k
David A. Wetter United States 34 416 0.3× 1.1k 1.0× 1.2k 1.1× 625 0.9× 127 0.2× 116 3.5k
José Torrealba United States 33 1.4k 1.1× 711 0.6× 506 0.5× 676 1.0× 169 0.3× 111 4.2k

Countries citing papers authored by N. Schleinitz

Since Specialization
Citations

This map shows the geographic impact of N. Schleinitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Schleinitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Schleinitz more than expected).

Fields of papers citing papers by N. Schleinitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Schleinitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Schleinitz. The network helps show where N. Schleinitz may publish in the future.

Co-authorship network of co-authors of N. Schleinitz

This figure shows the co-authorship network connecting the top 25 collaborators of N. Schleinitz. A scholar is included among the top collaborators of N. Schleinitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Schleinitz. N. Schleinitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rochigneux, Philippe, Antonella Bertucci, Daniel Robert, et al.. (2025). Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors. Frontiers in Immunology. 16. 1496427–1496427. 2 indexed citations
2.
Boucly, Athénaïs, Stéphane Mitrovic, Maryvonnick Carmagnat, et al.. (2025). Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15. Annals of the Rheumatic Diseases. 84(9). 1538–1548.
3.
Marie, B. De Sainte, J. Séguier, Roch Giorgi, et al.. (2024). État de santé et qualité de vie des patients β-thalassémiques adultes à Marseille, France. La Revue de Médecine Interne. 45(4). 187–193. 1 indexed citations
4.
Bourguiba, R., Samuel Deshayes, Gayane Amaryan, et al.. (2024). Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study. Rheumatology International. 44(12). 3107–3111.
5.
Nguyen, Yann, Adrien Michon, Bertrand Lioger, et al.. (2024). Création du club Greenternist : la médecine interne en transition écologique. La Revue de Médecine Interne. 45(7). 397–399. 2 indexed citations
6.
Daumas, Aurélie, A. Benyamine, Mikaël Ebbo, et al.. (2023). Hospitalisation pour infection chez les patients suivis pour une artérite à cellules géantes : étude monocentrique rétrospective. La Revue de Médecine Interne. 44(5). 212–217.
8.
Queyrel, V., N. Tieulié, Laurent Chiche, et al.. (2022). Importance of temporality and context in relation to life habit restrictions among patients with systemic lupus erythematosus: A psychosocial qualitative study. Lupus. 31(12). 1423–1433. 7 indexed citations
9.
Ramirez, Giuseppe A., Marco Lanzillotta, Mikaël Ebbo, et al.. (2021). Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study. Lara D. Veeken. 61(5). e109–e111. 5 indexed citations
10.
Goulenok, Tiphaine, Dorothée Faille, Nadine Ajzenberg, et al.. (2021). Acquired factor V inhibitor: a nation‐wide study of 38 patients. British Journal of Haematology. 192(5). 892–899. 7 indexed citations
11.
Comarmond, Cloé, Nathalie Saidenberg-Kermanac’h, N. Schleinitz, et al.. (2019). Osseous sarcoidosis: A multicenter retrospective case-control study of 48 patients. Joint Bone Spine. 86(6). 789–793. 19 indexed citations
12.
Benyamine, A., Mourad Boufi, N. Schleinitz, et al.. (2019). Atteintes macrovasculaires de la sclérodermie : état de la question en 2019. JMV-Journal de Médecine Vasculaire. 44(6). 400–421. 2 indexed citations
13.
Haroche, Julien, Jean‐François Emile, Frédéric Charlotte, et al.. (2018). La maladie de Destombes-Rosai-Dorfman : évolution du concept, classification et prise en charge. La Revue de Médecine Interne. 39(8). 635–640. 9 indexed citations
14.
Cally, Radj, Mikaël Ebbo, A. Grados, et al.. (2016). Comment j’explore une hypergammaglobulinémie polyclonale ?. 22(2). 104–108.
15.
Grados, A., Mikaël Ebbo, E. Bernit, et al.. (2015). Sarcoidosis Occurring After Solid Cancer. Medicine. 94(28). e928–e928. 36 indexed citations
16.
London, Jonathan, A. Grados, Christophe Fermé, et al.. (2014). Sarcoidosis Occurring After Lymphoma. Medicine. 93(21). e121–e121. 45 indexed citations
17.
Mahévas, Matthieu, Laurent Chiche, Y. Uzunhan, et al.. (2011). Association of Sarcoidosis and Immune Thrombocytopenia. Medicine. 90(4). 269–278. 18 indexed citations
18.
Schleinitz, N., Frédéric Vely, Jean‐Robert Harlé, & Éric Vivier. (2010). Natural killer cells in human autoimmune diseases. Immunology. 131(4). 451–458. 113 indexed citations
19.
Schleinitz, N., Pascale Poullin, Luc Camoin, et al.. (2007). Le purpura thrombotique thrombocytopénique acquis de l’adulte : actualités. La Revue de Médecine Interne. 29(10). 794–800. 5 indexed citations
20.
Vely, Frédéric, Marie‐Alix Peyrat, Jean‐François Morcet, et al.. (2001). Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements. The Journal of Immunology. 166(4). 2487–2494. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026